Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
NGO · Ireland
Consumer organization · Belgium
Declared costs: not declared · in the register since 2008
Medicinal products for human use · Compulsory licensing of patents in crisis situations
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Access to Medicines Ireland · filed 26 Apr 2021 · source
Access to Medicines Ireland (AMI) welcomes the opportunity to contribute to the revision of the general pharmaceutical legislation. We have comments, and recommendations in the following areas: Unmet Need 1. Towards a definition of ‘unmet need’, we recommend developing a fair, equitable and transparent decision-making process for what is an ‘unmet need’. 2.
BEUC - The European Consumer Organisation · filed 27 Apr 2021 · source
BEUC supports the European Commission’s initiative to evaluate and revise the general pharmaceutical legislation to improve access to medicines. We agree with the main gaps identified in the roadmap and corrective measures, but have additional recommendations. These are the most pressing issues and necessary changes for consumers: Unmet medical needs: Antimicrobial resistance is a global public health-threat.
BEUC - The European Consumer Organisation · filed 8 Nov 2023 · source
The European Commission proposal for a revised EUs pharmaceutical legislation is a step in the right direction as it includes recommendations from BEUC on ways to improve access to medicines in Europe. We strongly support measures to increase transparency on public funding for biomedical research, facilitate the development of medicines by non-profit entities, and enhance EU cooperation and action in the prevention…
Access to Medicines Ireland · filed 29 Apr 2022 · source
Compulsory Licensing in the EU: Call for Evidence Submission by Access to Medicines Ireland (AMI) 29 April 2022 [max 4000 characters] AMI is a voluntary membership group of Cómhlamh, and we welcome the opportunity to provide feedback on the EU’s proposal to review the compulsory licensing in Europe.
BEUC - The European Consumer Organisation · filed 31 Jul 2023 · source
BEUC welcomes the European Commission's proposal for a regulation on compulsory licensing for crisis management. Such a framework is necessary to enable a swift and appropriate response to a crisis or emergency by guaranteeing the supply and the free movement of crisis-critical patented products in the Single Market. However, the Commissions proposal calls for certain improvements: 1.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.